PERCHLORACAP
LOE Approachingpotassium perchlorate
NDAORALCAPSULE
Approved
Nov 1974
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 13h ago · AI intelligence enriched 2mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PERCHLORACAP (potassium perchlorate) is an oral capsule small molecule approved in 1974 for suppression of thyroid uptake of radioactive iodine, particularly in nuclear medicine imaging and therapeutic contexts. It acts as a competitive inhibitor of iodide transport into the thyroid gland. The drug serves a specialized, niche indication in nuclear medicine and radioactive iodine therapy protocols.
LOE Approaching
Approaching loss of exclusivity with minimal linked job opportunities reflects a mature, specialty product with limited commercial expansion potential and likely small, stable team size.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
PERCHLORACAP represents a niche specialty product with zero linked job opportunities, indicating minimal hiring activity and limited career mobility within the franchise. Working on this product offers stable but narrow expertise in nuclear medicine, suitable for specialists but with restricted growth trajectory and market evolution.
Medical Science LiaisonField Sales Representative
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.